Skip to content

Effect of nebulized eucalyptus on prevention of ventilator-associated pneumonia in ventilated patient

Effect of nebulized eucalyptus on prevention of ventilator-associated pneumonia in ventilated patient

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161014030294N3
Enrollment
70
Registered
2020-08-23
Start date
2020-05-25
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventilator-associated pneumonia.

Interventions

Intervention 1: Intervention group: Nebulizing eucalyptus. In the patients of the intervention group, 4 drops of ready eucalyptus solution (Darou Gostar Barij Essence co ) is diluted in 6 ml of 0.9% n

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: Obtaining the consent of the treating physician, presence of endotracheal tube, age 16 to 65 years, mechanical ventilation for at least 72 hours, no lung infection based on the clinical score of modified lung infection (MCPIS), no sensitivity to plant compounds, no Presence of sepsis, pulmonary thromboembolism, atelectasis, inflammatory diseases of the gastrointestinal tract, bile ducts and severe liver disease at the discretion of a specialist (based on physical examination and history taken from the patient).

Exclusion criteria

Exclusion criteria: Transfer of the patient from the ICU (for any reason) or death before the completion of the study, unwillingness of the patient's companions to continue the study, chest surgery, observation of complications due to eucalyptus fumigation such as urticaria, pruritus and skin rash, sudden changes in The patient's clinical condition or respiratory pattern, worsening of the patient's general condition, or decreased level of consciousness due to possible infection.

Design outcomes

Primary

MeasureTime frame
Type of microbial contamination of patients' lung secretions. Timepoint: Samples of endotracheal secretions for microbiological studies 72 hours, 7 days and 15 days after inhalation and when the patient is extubated. Method of measurement: Microbiological test.

Secondary

MeasureTime frame
Incidence of possible complications. Timepoint: From the beginning of the intervention continuously. Method of measurement: observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansoreh Karimikia

Arak University of Medical Sciences

m.karimikia@arakmu.ac.ir+98 86 3367 4702

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026